Dapagliflozin 10mg Glimepiride 2mg Metformin 500mg | GLIDAPAFLOZIN TRIO 2

Glidapaflozin Trio 2 is a comprehensive triple fixed-dose combination (FDC) designed for patients with Type 2 Diabetes Mellitus whose blood glucose remains inadequately controlled despite dual therapy or who present with more significant hyperglycemia requiring a multi-mechanism approach from the outset. By bringing together three distinct, well-established antidiabetic drug classes into a single tablet, this formulation offers comprehensive glycemic control while meaningfully simplifying what would otherwise be a complex, multi-tablet regimen.

Manufactured by Steris Healthcare, this combination is prescribed by physicians, endocrinologists, and diabetologists across India for patients requiring intensified oral antidiabetic therapy, reflecting the reality that Type 2 Diabetes is a progressive condition often requiring escalating, multi-mechanism treatment over time.

Product Information

Why It's Important

Type 2 Diabetes Mellitus is a progressive condition, and as beta-cell function naturally declines over years of disease duration, many patients eventually require more than two antidiabetic agents to achieve and sustain adequate glycemic control. In India, where diabetes often goes undiagnosed for years before detection, patients frequently present with more advanced disease and higher baseline blood glucose levels, making comprehensive, multi-mechanism therapy clinically necessary sooner than might be expected in earlier-detected cases.

This is precisely why a rational triple combination like Glidapaflozin Trio 2 holds such significant clinical importance. Rather than requiring patients to manage three separate tablets — each with its own dosing schedule and pill burden — this fixed-dose combination brings together metformin's foundational glucose-lowering mechanism, glimepiride's potent insulin-secretagogue action, and dapagliflozin's insulin-independent renal glucose excretion into a single, convenient tablet. This three-pronged approach allows physicians to address multiple facets of Type 2 Diabetes pathophysiology simultaneously — insulin deficiency, insulin resistance, and excess glucose reabsorption — often achieving meaningfully greater HbA1c reduction than any two of these mechanisms alone.

Beyond glycemic benefit, the inclusion of dapagliflozin in this triple combination also brings additional cardiovascular and renal protective potential, which is particularly relevant for patients with more advanced or longer-standing Type 2 Diabetes, who often carry elevated cardiovascular and chronic kidney disease risk. Simplifying such a comprehensive treatment regimen into one tablet also meaningfully supports medication adherence — a critical factor for patients managing what is often a complex, multi-condition treatment plan alongside other medications for blood pressure, cholesterol, or other comorbidities.

The reliability of a WHO-GMP and ISO 9001:2018 certified manufacturer like Steris Healthcare is especially critical for a triple fixed-dose combination like this, where consistent, uniform distribution of all three active ingredients across every tablet directly affects both glycemic reliability and the safety margin required when a sulfonylurea component is involved.

Key Benefits 

What Are the Benefits of Glidapaflozin Trio 2?

Dapagliflozin 10mg + Glimepiride 2mg + Metformin Hydrochloride 500mg, as formulated in Glidapaflozin Trio 2, offers several clinically meaningful advantages:

• Comprehensive triple mechanism of action: Combining an SGLT2 inhibitor, a sulfonylurea, and a biguanide addresses glucose control through three independent pathways, often achieving substantially greater HbA1c reduction than dual therapy.
• Effective for more advanced Type 2 Diabetes: Particularly valuable for patients with higher baseline blood glucose or longer disease duration, where single or dual therapy alone may be insufficient.
• Modest weight offset: While glimepiride can be associated with modest weight gain, dapagliflozin's glucose and calorie loss through urine can help offset this effect, supporting a more balanced overall weight profile compared to sulfonylurea-metformin combinations alone.
• Cardiovascular and renal benefit potential: The dapagliflozin component contributes established cardiovascular and renal protective benefits, adding value beyond glycemic control alone.
• Simplified triple-therapy dosing: Combining three active ingredients into a single tablet significantly reduces pill burden for patients who would otherwise need multiple separate medications, supporting better adherence.
• Potential to delay insulin initiation: For appropriately selected patients, comprehensive oral triple therapy can help maintain glycemic control for longer, potentially delaying the need for injectable insulin therapy.
• Established individual component safety profiles: Each of the three components has extensive individual clinical use, providing physicians with a well-understood foundation for combined prescribing.
• Trusted manufacturing standards: Glidapaflozin Trio 2 is manufactured by Steris Healthcare, a WHO-GMP and ISO 9001:2018 certified pharmaceutical company, ensuring consistent potency and reliable quality across every batch — particularly important given the precision required for a three-component combination.

Side Effects 

Because this is a triple combination product, side effects may arise from any of the three components. Commonly reported side effects include:

• Gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort, particularly associated with the metformin component
• Urinary tract infections, due to increased glucose concentration in urine from Dapagliflozin
• Genital fungal infections, also related to glucosuria
• Increased urination frequency
• Mild headache
• Dizziness
• Metallic taste, occasionally reported with metformin

Most gastrointestinal effects tend to improve with continued use or can be minimized by taking the tablet with food.

Precautions & Warnings

Before starting Glidapaflozin Trio 2, patients and prescribers should consider the following precautions:

• Hypoglycemia Risk: Due to the glimepiride component, this combination carries a meaningfully higher hypoglycemia risk than dual therapy without a sulfonylurea; patients should be thoroughly educated on recognizing and managing low blood sugar.
• Renal Impairment: All three components require careful renal function assessment; metformin is generally contraindicated in significant renal impairment, and both glimepiride and dapagliflozin require dose or suitability adjustment based on kidney function.
• Elderly Patients: Require particular caution given compounded risks of hypoglycemia, dehydration, and renal function changes.
• Volume Depletion: Patients on diuretics or with low blood pressure should be monitored for dehydration, particularly during treatment initiation.
• Genital and Urinary Infections: Patients should be counseled on genital hygiene practices to reduce infection risk associated with glucosuria.
• Diabetic Ketoacidosis Risk: Patients should be aware of ketoacidosis signs and should temporarily discontinue therapy during acute illness or significantly reduced food intake, as directed by the physician.
• Lactic Acidosis Risk Factors: Caution is required in patients with conditions predisposing to lactic acidosis, including significant liver disease or heavy alcohol use.
• Sulfa Allergy: Patients with a known allergy to sulfonamide-derived medications should discuss this with their physician before starting glimepiride-containing therapy.
• Pregnancy and Lactation: This combination is generally not recommended during pregnancy or breastfeeding.
• Alcohol Use: Should be used cautiously with alcohol, given increased hypoglycemia risk with glimepiride and lactic acidosis risk with metformin.

Mechanism of Action 

Glidapaflozin Trio 2 works through three independent, complementary mechanisms:

Dapagliflozin (SGLT2 Inhibitor): Selectively inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidney's proximal tubule, reducing glucose reabsorption and promoting insulin-independent urinary glucose excretion, while also contributing modest weight reduction and blood pressure benefit.

Glimepiride (Sulfonylurea): Stimulates insulin release from pancreatic beta cells by binding to sulfonylurea receptors on the beta-cell membrane, closing ATP-sensitive potassium channels and triggering calcium influx that promotes insulin secretion, independent of current blood glucose levels — which is the basis for its associated hypoglycemia risk.

Metformin Hydrochloride (Biguanide): Reduces hepatic gluconeogenesis (glucose production by the liver), improves peripheral insulin sensitivity in skeletal muscle, and modestly reduces intestinal glucose absorption, working through activation of AMP-activated protein kinase (AMPK) at the cellular level.

Combined Effect: Together, these three mechanisms — insulin secretion stimulation, reduced hepatic glucose output with improved insulin sensitivity, and insulin-independent renal glucose excretion — provide comprehensive, multi-pathway glycemic control that addresses the several overlapping pathophysiological defects characteristic of more advanced Type 2 Diabetes Mellitus.

Frequently Asked Questions (FAQ)

1. Where can I buy Dapagliflozin Glimepiride and Metformin online?
You can purchase Dapagliflozin Glimepiride and Metformin through licensed online pharmacies or authorized pharmaceutical suppliers. Verify the manufacturer, strengths, batch number, expiry date, and packaging before purchasing.

2. What is the price of Dapagliflozin Glimepiride and Metformin?
The price may vary depending on the brand, strengths, formulation, pack size, manufacturer, seller, and applicable pharmacy charges. Check the current listed price before ordering.

3. Can I order Dapagliflozin Glimepiride and Metformin online?
Yes, this combination can be ordered online where legally available. Since it contains prescription medicines, purchase it through a licensed pharmacy and provide a valid prescription when required.

4. Is Dapagliflozin Glimepiride and Metformin available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm availability, strengths, pack size, and ordering details.

5. What is Dapagliflozin Glimepiride and Metformin used for?
This combination is used to help control blood glucose levels in adults with type 2 diabetes mellitus, along with an appropriate diet and exercise plan. The three medicines work through different mechanisms to improve blood glucose control.

6. What is the composition of Dapagliflozin Glimepiride and Metformin?
The combination contains Dapagliflozin, Glimepiride, and Metformin as active pharmaceutical ingredients. The exact strengths and formulation may vary depending on the specific product.

7. Is a prescription required?
Yes, this combination is generally a prescription medicine and should be used under the supervision of a qualified healthcare professional. The prescribed strengths should not be changed without medical advice.

8. How should Dapagliflozin Glimepiride and Metformin be taken?
Take the medicine exactly as prescribed by your doctor. It is commonly taken with food to help reduce stomach-related effects and may help lower the risk of low blood sugar associated with glimepiride. Follow the specific dosing instructions for your formulation and do not change or stop treatment without medical advice.

9. What should I know before buying Dapagliflozin Glimepiride and Metformin?
Before purchasing, verify the exact strengths, formulation, manufacturer, batch number, expiry date, packaging, and storage instructions. Inform your healthcare professional about kidney or liver problems, dehydration, recurrent urinary or genital infections, pregnancy or breastfeeding, and all other medicines you take. This combination can cause low blood sugar in some patients.

10. How can I order Dapagliflozin Glimepiride and Metformin online?
Order through a licensed online pharmacy or authorized pharmaceutical supplier. Select the prescribed formulation and strengths, provide a valid prescription if required, and verify the manufacturer, batch number, expiry date, and delivery details before completing your purchase.